Form 10-K for the Fiscal Year Ended December 31, 2023
In your discussion of net sales and gross profit, you cite multiple factors as impacting your results of operations but provide no quantification of the contribution of each factor to the material changes nor do you provide any context for the underlying reasons for such changes.Rest of the question
Where one or more factors contributed to a material change in a line item, please revise future filings to describe the underlying reasons for these changes in quantitative and qualitative terms. We refer to guidance in Item 303(b) of Regulation S-K. Exhibit 99.1
In response to the Staff’s comment, the Company will quantify each such material factor in its future filings with the Commission to enhance an investor’s understanding of the magnitude and relative impact of each such material factor.Read in the reply
First report after the company's reply of Sep 20, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note your non-GAAP reconciliations appear to include a full non-GAAP income statement. The presentation of a full non-GAAP income statement, or a presentation that gives the appearance of one, may place undue prominence on the non-GAAP information and give the impression that the non-GAAP income statement represents a comprehensive basis of accounting. Please remove this presentation in your future filings.Rest of the question
To the extent you wish to present any of the non-GAAP measures, you should present a separate reconciliation for each non-GAAP measure and provide all the disclosures required by Item 10(e)(1)(i) of Regulation S-K including quantification and description of each adjustment individually. Refer to Question 102.10(a) and (c) of the C&DIs for Non- GAAP Financial Measures.
The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Company has considered Question 102.10 of the Compliance and Disclosure Interpretations (“C&DIs”) for Non-GAAPRead in the reply
Financial Measures and the application of Regulation G and Item 10(e) of Regulation S-K. The Company will remove the referenced disclosures in its future filings so that the reconciliation tables do not resemble a full non-GAAP income statement.Rest of the answer
The Company has included in Appendix A an illustrative disclosure based on the three-month and six-month periods ending
June 30, 2023 and June 30, 2024, respectively, which the Company anticipates will be substantially similar to the disclosure it will use commencing with the Company’s earnings release furnished on Form
8-K for the quarter ending September 30, 2024 and on a going forward basis for each applicable non-GAAP measure, including a quantification and description of each adjustment individually, in lieu of the prior disclosure referenced by the Staff.
First report after the company's reply of Sep 20, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
In future filings, please include a separate footnote for each non-GAAP adjustment that describes in further detail the adjustment, the related facts and circumstances and the reason why the adjustment is included. Please provide us any proposed disclosure.
The Company respectfully acknowledges the Staff’s comment and refers the Staff to Appendix A for an illustrative disclosure based on the three-month and six-month periods ending June 30, 2023 and June 30, 2024, respectively, which the Company anticipates will be substantially similar to the disclosure it will use commencing with the Company’s earnings release furnished on Form 8-K for the quarter ending September 30, 2024 and on a going forward basis.Read in the reply
First report after the company's reply of Sep 20, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We note certain non-GAAP adjustments for 2023 and 2022 include bad debt reserve related to an international customer, expenses for certain legal proceedings, and inventory reserve due to changes in raw material regulation. Please describe these adjustments to us in further detail and tell us how you considered the guidance in Question 100.01 of the C&DIs for Non-GAAP Financial Measures.
The Company respectfully acknowledges the Staff’s comment and advises the Staff that it has considered the guidance set forth in Question 100.01 of the C&DIs on Non-GAAP Financial Measures and the requirements set forth in Item 10(e) of Regulation S-K. Based on that guidance, theRead in the reply
Company believes the charges incurred related to the aforementioned matters are unusual or infrequent, are not typical of ongoing operations, and as such do not represent normal, recurring operating costs.Rest of the answer
In determining whether a matter does not constitute normal, recurring expenses necessary to operate the business, the Company considers the nature, scope, frequency and potential magnitude of each matter. The adjustments for the bad debt reserve related to an international customer, expenses for certain legal proceedings, and inventory reserve due to changes in raw material regulation are further described below ($ in millions).
Bad debt reserve: In fiscal year 2022, the Company recorded a $9 million charge to establish a bad debt reserve for accounts receivable due from an international customer that filed for bankruptcy. The Company believes the bankruptcy of a customer and associated bad debt expense of this magnitude to be an infrequent occurrence, which does not represent a normal, recurring operating cost. While the Company does incur bad debt expense in the ordinary course, it does not typically experience customer bankruptcies leading to charges of this magnitude. Prior to the item cited by the Staff, the last customer bankruptcy resulting in a one-time charge of this magnitude that was adjusted in normalized results occurred in 2018. As disclosed by the Company in its earnings release for the quarter ending March 31, 2024 furnished on Form 8-K on April 26, 2024, the Company subsequently received a payment of $9 million from the international customer as administered by the bankruptcy court. Consistent with the aforementioned charge, the Company also reflected the recovery of the bad debt as a non-GAAP adjustment presented for the quarter ended March 31, 2024.
Certain legal proceedings: In fiscal years 2023 and 2022, the Company recorded $11 million and $30 million, respectively, of legal expenses for certain proceedings. These expenses were primarily related to a completed U.S. Securities and Exchange Commission investigation as well as completed shareholder securities class action and derivative litigation, each of which is disclosed in Note 18 (Litigation and Contingencies) to its audited consolidated financial statements contained in its most recent Annual Report filed on Form 10-K on February 21, 2024. The Company believes the legal expenses incurred as a result of these matters are unusual, infrequent, and not typical of ongoing operations, and as such do not represent normal, recurring operating costs.
Inventory reserve: In fiscal year 2023, the Company recorded a $11 million inventory write-down due to the adoption of regulatory restrictions on the sale of certain of its products in select jurisdictions. The Company purchased the inventory based on a combination of historical sales, demand planning and other factors, but the salability of such inventory was ultimately impacted by the announcement and adoption of regulations that restricted the sale of certain products beyond a stipulated date. While regulatory restrictions impacting the sale of the Company’s products do occur from time to time, a change of law that results in a one-time inventory write-down of this magnitude is an unusual and infrequent occurrence, which does not represent a normal, recurring operating cost.
First report after the company's reply of Sep 20, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Please tell us and revise future filings to detail the nature and composition of the non- GAAP adjustment to cost of products sold and selling, general and administrative expenses for "restructuring-related" costs. In your response, please tell us how you considered Question 100.01 of the Division of Corporation Finance's Compliance & Disclosure Interpretations on Non-GAAP Financial Measures.
The Company respectfully acknowledges the Staff’s comment and advises the Staff that it has considered the guidance set forth in Question 100.01 of the Compliance and C&DIs on Non-GAAP Financial Measures and the requirements set forth in Item 10(e) of Regulation S-K with respect to the presentation of restructuring-related costs as a non-GAAP adjustment.Read in the replyRest of the answer
The Company is in the process of a multi-year transformation of its operating model, front-end capabilities and supply chain, as discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations – Business Strategy contained in the
Company’s most recent Annual Report filed on Form 10-K on February 21, 2024. In connection with these initiatives, the Company has initiated various major restructuring actions, such as our
Realignment Plan commenced and expected to be substantially implemented by the end of 2024, Network Optimization Project commenced in 2023 and expected to be substantially completed in 2024 and Project Phoenix commenced and mostly completed in 2023, as well as other discrete actions as disclosed in its current reporting on its most recent Form 10-Q and Form 10-K, which were filed on July 26, 2024 and
February 21, 2024, respectively. In connection with these actions, the Company incurs restructuring costs consistent with applicable accounting standards, including Accounting Standards Codification No. 420 and No. 712 (e.g., severance and other employee termination costs as well as contract termination and other costs), which the Company presents as a non-GAAP adjustment. Also associated with these actions, the Company incurs restructuring-related costs, which are costs that are directly attributable to a restructuring action and would not have been incurred absent the action (e.g., duplicative costs pending facility closure or exit of business activity, asset valuation adjustments and disposal gains or losses, accelerated depreciation, and consulting costs). The Company considers such initiatives to be transformational in nature and does not consider the associated restructuring costs and restructuring-related costs incurred, which vary significantly from period to period based on the timing of projects, to represent normal, recurring operating costs. Therefore, restructuring costs and restructuring-related costs are presented as a non-GAAP adjustment. Restructuring-related costs primarily related to manufacturing and distribution personnel, facilities and assets are generally recorded in cost of products sold, while restructuring-related costs primarily related to office facilities and assets and professional or clerical personnel are generally recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.
APPENDIX A
The following tables present a reconciliation of certain non-GAAP financial measures to the most directly comparable financial measures in accordance with GAAP for the three and six months ended June 30, 2024 and a comparison to prior year. The Company has chosen to present the following non-GAAP measures to investors to enable additional analyses of past, present and future operating performance and as a supplemental means of evaluating the Company’s performance and operating results absent the effect of certain items that are deemed to be stand-alone items apart from the Company’s core operations (“Normalized Adjustments”). While these costs or gains are not expected to continue for any individual transaction on an ongoing basis, similar types of costs, expenses and charges or gains have occurred in prior periods.
Normalized Adjustments in 2024 and 2023 include the following:
Restructuring and restructuring-related costs
The Company incurs restructuring and restructuring-related charges in connection with various discrete initiatives, including previously disclosed initiatives such as our Realignment Plan, Network Optimization Project, Project
Phoenix as well as other discrete actions. Restructuring charges primarily relate to severance and other employee termination costs as well as contract termination and other costs. Restructuring-related charges are costs that are directly attributable to a restructuring action and would not have been incurred absent the action. Restructuring-related charges primarily relate to duplicative costs pending facility closure, asset valuation adjustments and disposal gains or losses, accelerated depreciation, and consulting costs. Restructuring-related costs primarily related to manufacturing and distribution personnel, facilities and assets are generally recorded in cost of products sold, while restructuring-related costs primarily related to office facilities and assets and professional or clerical personnel are generally recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations. Restructuring and restructuring-related charges primarily related to the Realignment Plan for the three and six months ended June 30, 2024 and to Project Phoenix for the comparable periods ended June 30, 2023, respectively.
Amortization expense and impairments of acquired intangible assets
Represent the amortization expense and impairment charges associated with acquired intangible assets.
Argentina hyperinflationary currency movements
Represents the favorable or unfavorable movement in Argentine pesos related to our subsidiary operating in Argentina, which is considered a hyperinflationary economy.
(Gain) loss on divestitures and transaction costs
Represents the gain or loss on disposal of a business, which represents the difference between the fair value (less costs to sell) and carrying value of the business being disposed, as well as transaction costs associated with acquisitions and divestitures.
Other adjustments
The following adjustments comprise other adjustments below: Release of bad debt reserve related to the bankruptcy of an international customer; legal expenses for certain proceedings primarily related to a completed U.S. Securities and Exchange Commission investigation as well as completed shareholder securities class action and derivative litigation which is disclosed in Note 18 (Litigation and Contingencies) to our audited consolidated financial statements contained in our most recent annual report on Form 10-K; accelerated depreciation and amortization as well as the write-off of other assets associated with retail stores closure and software integration; the portion of a tax reserve associated with prior periods that was recorded due to the outcome of a judicial ruling relating to indirect taxes in an international entity; gains/losses arising from the mark-to-market of an investment with a readily determinable fair value; loss on modification of debt; loss on pension settlement; and an insurance recovery related to fire-related costs that were previously normalized.
Normalized income tax adjustments
The company uses a “with” and “without” approach to calculate normalized income tax expense or benefit. At an interim period, the company determines the year-to-date tax effect of the pretax items excluded from normalized results by allocating the difference between the calculated GAAP and calculated normalized tax expense or benefit. In addition, normalized income tax adjustments includes the income tax expense ($12 million and $14 million for the three months ended June 30, 2024 and 2023, respectively, $22 million and $23 million for the six months ended June 30, 2024 and
2023, respectively) that results from the amortization of a prior year normalized tax benefit.
NEWELL BRANDS INC.
RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)
CERTAIN LINE ITEMS
(Amounts in millions, except per share amounts)
Three Months Ended
June 30,
Six Months Ended
2024
2023
Gross profit, as reported under GAAP
$
699
629
1,203
1,111
As a % of net sales
34.4
%
28.5
32.6
27.7
Normalized Adjustments:
Argentina hyperinflationary charge
Normalized gross profit
708
658
1,224
1,147
34.8
29.9
33.2
28.6
Operating income, as reported under GAAP
163
120
179
8.0
5.4
4.9
2.1
Amortization of acquired intangible assets
Impairment of acquired intangible assets
—
(1
)
Other, net
(4
Normalized operating income
219
201
295
244
10.8
9.1
6.1
Income (loss) before income taxes, as reported under GAAP
(81
(3
Normalized income before income taxes
137
117
140
Income tax provision (benefit), as reported under GAAP
(12
Effective income tax rates, as reported under GAAP
46.4
48.6
(50.0
)%
3.7
(53
Normalized income tax provision (benefit)
(14
(9
Normalized effective income tax rates
(10.2
13.7
(6.4
16.7
Net income (loss), as reported under GAAP
(84
Normalized net income
151
101
149
Diluted earnings (loss) per share, as reported under GAAP
0.11
0.04
0.09
(0.20
0.06
0.16
0.22
0.05
0.12
0.02
0.01
(0.01
0.13
(0.03
Normalized diluted earnings per share*
0.36
0.24
0.18
*
Totals may not add due to rounding.
First report after the company's reply of Sep 20, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We have reviewed your response to comment 4. Despite the circumstances indicated in your response, credit losses related to customers and lower of cost or net realizable value adjustments to inventory appear to represent normal, recurring operating expenses necessary to operate your business as addressed in Question 100.01 of the Compliance and Disclosure Interpretations for Non-GAAP Financial Measures.Rest of the question
In this regard, in future filings, please remove these components from your adjustment.
In response to the Staff’s comment, the Company acknowledges that credit losses related to customers and lower of cost or net realizable value adjustments to inventory are typically considered operating expenses that arise from time to time in the ordinary course of business, and therefore are not typically reflected as adjustments to non-GAAP measures.Read in the replyRest of the answer
However, the Company believes that its write-downs of accounts receivable ($9 million) and inventory ($11 million), which relate to the bankruptcy of a customer and regulatory restrictions banning the salability of certain of its products in certain jurisdictions, are of a nature and magnitude that renders them an unusual and infrequent occurrence. Absent exceptional circumstances, the Company considers an event to be infrequent where (i) there are no similar charges or gains occurring within the previous two years and (ii) similar charges or gains are not reasonably likely to reoccur within the two subsequent years thereafter, which the
Company believes was the case for both matters discussed herein.
Bad debt reserve: As indicated in our initial response, the last time the Company reflected a bad debt expense arising from a customer bankruptcy as a non-GAAP adjustment was during 2018. Despite the Company’s belief that this non-GAAP adjustment complies with the guidance in Question 100.01 of the Compliance and Disclosure Interpretations (“CDIs”) for Non-GAAP
Financial Measures, the Company acknowledges that it will remove the adjustment for the above-referenced bad debt reserve from its non-GAAP measures when and if any relevant period is presented in the future.
The Company also acknowledges that it will remove the non-GAAP adjustment previously presented for the quarter ended March 31, 2024, which relates to the recovery of the aforementioned bad debt that was received from the international customer as administered by the bankruptcy court. The Company will present this change commencing with the Company’s third quarter earnings release furnished on Form 8-K for the quarter ending September 30, 2024 (specifically, for the nine-month period ending September 30, 2024) and on a going forward basis, as necessary.
Inventory reserve: The Company respectfully disagrees with the Staff’s position to remove the non-GAAP adjustment for the write-down of inventory arising from the regulatory restrictions impacting the sale of its products. The Company believes that it is not only the nature but also the frequency and effect an item has on its underlying operating results and period-over-period comparability when determining whether an adjustment should be presented as a non-GAAP adjustment. The Company recorded this inventory write-down due to the adoption of regulatory restrictions in various jurisdictions that banned the sale of certain products containing specified substances and, in the Company’s case, rendered such items effectively unsalable in the
United States. While changes in governmental regulations occur in the ordinary course of business, the Company is not aware of a similar situation, where a product ban required an inventory write-down of this magnitude, occurring in its history. The
Company believes this specific inventory write-down to be a non-recurring, non-cash operating expense that has not occurred repeatedly or even occasionally and, as such, the presentation of this matter as a non-GAAP adjustment complies with the guidance in Question 100.01 of the CDIs for Non-GAAP Financial Measures. The Company therefore believes that the presentation of this write-down of inventory as a non-GAAP adjustment is appropriate.
First report after the company's reply of Oct 4, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We reference your response to comment 5 related to restructuring-related costs. For the $86 million restructuring related adjustment to cost of products sold and the $13 million restructuring related adjustment to selling, general and administrative expense, please quantify each of the underlying adjustments indicated in your response.Rest of the question
Please also respond to the following comments to help us better understand the nature of the amounts and your consideration of the guidance in Question 100.01 of the Compliance and Disclosure Interpretations for Non- GAAP Financial Measures in determining that it was appropriate to adjust for each of the items in the adjustment. • Regarding the adjustment for accelerated depreciation, please explain the nature of the underlying assets, whether the assets continue to be used in operations, and when you intend to retire the assets; • Explain the nature of the duplicative costs pending facility closure or exit of business activity, including how you calculated the amount that is duplicative and explain how you determined that these are costs to exit businesses or sites; • Tell us the nature of the services provided by the consultants; and • Explain the asset valuation adjustments and disposal gains or losses, including the nature of the assets, means of disposal, and when and why the assets were impaired.
The following table presents restructuring-related costs classified in cost of products sold and selling, general and administrative expenses (“SG&A”) by the underlying adjustments indicated in the Company’s response for the twelve-months ended December 31, 2023:Read in the reply
Restructuring-related costs:
Classified in
Cost of
Products Sold
SG&A
Total
Restructuring-
Related Costs
Asset valuation adjustments and disposal gains or losses
$
(6
)
Accelerated depreciation
Duplicative costs pending facility closure or exit of business activity
Consulting costs
—
As discussed in our responseRest of the answer
letter dated September 20, 2024, the Company is in the process of implementing a multi-prong transformative agenda, which involves various restructuring and organizational initiatives designed to, among other things, transform the Company’s go-to-market capabilities, improve customer service levels and drive operational efficiencies; improve the Company’s cost structure and operating margins; leverage the Company’s scale to reduce complexity, streamline its operating model and drive operational efficiencies; and strengthen the Company’s front-end commercial capabilities. These initiatives include the following:
Project Ovid, which completed its first phase go-live in 2022 and its second phase go-live in 2023, and was designed to optimize the Company’s distribution network by creating a single integrated supply chain from 23 business-unit-centric supply chains.
The Network Optimization Project, initiated in 2023 and expected to be substantially implemented by the end of
2024, which incorporates a variety of initiatives, including a reduction in the overall number of distribution centers, an optimization of distribution by location, and completion of select automation investments intended to further streamline the
Company’s cost structure and to maximize operating performance.
Project Phoenix, initiated and substantially implemented in 2023, which incorporated a variety of initiatives designed to simplify the organizational structure, streamline the Company’s real estate portfolio, centralize the Company’s supply chain functions, which included manufacturing, distribution, transportation and customer service, transition to a unified One Newell go-to-market model in key international geographies, and otherwise reduce overhead costs.
The Company’s organizational realignment, implemented in the first quarter 2024 and expected to be substantially implemented by the end of 2024 (subject to local law and consultation requirements), which incorporates various operating model changes, including standing up a cross-functional brand management organization, realigning business unit finance to fully support the new global brand management model, further simplifying and standardizing regional go-to-market organizations, and centralizing domestic retail sales teams, the digital technology team, business-aligned accounting personnel, the Manufacturing Quality team, and the Human Resources functions into the appropriate center-led teams. The organizational realignment will also further optimize the Company’s real estate footprint and pursue other cost reduction initiatives.
The restructuring-related costs described below are a direct result of the Company’s restructuring actions and exit activities that are necessary to effect this transformation, including facility closures and operating model changes, and they do not reflect normal facets of the Company’s ongoing operations as contemplated by Question 100.01 of the Compliance and Disclosure Interpretations on Non- GAAP Financial Measures.
Accelerated depreciation: The assets associated with the adjustment for accelerated depreciation charges include buildings such as distribution centers, warehouses, manufacturing facilities or offices used for sales and administrative purposes; leasehold improvements; or machinery and equipment, where such accelerated depreciation charges relate directly to an underlying restructuring action or exit activity. Accelerated depreciation represents the incremental depreciation expense realized in the relevant period arising from the difference between the asset’s original useful life and the shortened remaining useful life as a result of the restructuring action or exit activity. The remaining useful life, which is determined at the time the restructuring action or exit activity is approved and is on average is no more than twelve months, is generally the period from the commencement of the action through the anticipated exit or cease use date of the underlying asset, at which point the asset is no longer in operation and is retired. The Company believes accelerated depreciation represents an incremental non-cash charge that is directly attributable to a restructuring action and would not have been incurred absent the action.
Duplicative costs pending facility closure or exit of business activity: Certain of the Company’s restructuring actions result in the closure and consolidation of one or more existing facilities into one or more new facilities, as well as changes in the operating model of certain functional activities. As a result, the Company sometimes incurs duplicative operating costs pending the commencement of the new facility’s operation or the commencement of the new operating model until completion of the restructuring or exit activity and corresponding transition to the new facility or operating model. The period of incurring duplicative costs is generally short term in duration and on average is no more than six months. The duplicative costs include primarily one-time freight costs associated with relocating inventory, start-up costs to get the new facility ready for operations, employee compensation expense including salary and benefits as well as retention bonuses for certain employees, and third-party transition costs associated with outsourcing of certain global business services. The Company believes these duplicative costs represent incremental charges with no ongoing economic benefit that are directly attributable to a restructuring action or change in operating models that would not have been incurred absent the action or change.
Consulting costs: The non-GAAP adjustment for restructuring-related costs includes only those consulting costs which are directly attributable to one or more restructuring actions or exit activities. For the twelve months ending
December 31, 2023, such costs primarily related to planning for the Company’s Network Optimization Project with respect to its distribution network and restructuring actions associated with certain of the Company’s manufacturing facilities.
Asset valuation adjustments and disposal gains or losses: The following table presents asset valuation adjustments and disposal gains or losses classified in cost of product sales and SG&A for the twelve-months ended December 31, 2023, which are included in the Company’s non-GAAP adjustment for restructuring-related costs noted above:
Asset valuation adjustments and disposal gains or losses:
Inventory write-downs
Construction-in-progress impairment charges
Lease expense associated with right-of-use asset facility exit costs
Costs associated with decommissioning assets
Gain on disposition of assets associated with restructuring action
(1
(17
(18
Inventory write-downs: Prior to closing a manufacturing facility, distribution center or warehouse as a result of a restructuring action, the Company is required to clear all of the inventory from the location, either through donation, destruction, relocation or liquidation, prior to exiting the facility. In 2023, the Company incurred charges to write-down the value of inventory as a result of inventory clearance at facilities slated for closure, as described below.
The Company closed four domestic manufacturing facilities in 2023 pursuant to an approved restructuring plan or exit activity. The Company considers many factors including its manufacturing capacity, demand planning, and current customer orders, as well as historical order activity, to determine the level of raw materials and work-in-process (“WIP”) that would be required to manufacture a sufficient quantity of finished goods prior to the closure of a manufacturing facility. After assessing its manufacturing needs and alternative uses, the Company concluded that there were stranded raw materials and WIP held at certain manufacturing facilities that were being closed pursuant to an approved restructuring plan or exit activity, which resulted in total write-downs of raw materials and WIP of approximately $8 million for the twelve months ending December 31, 2023. An additional
$1 million write-off of raw materials and WIP was recorded as a result of a brand exit in the Home and Commercial Solutions segment, following a comprehensive brand assessment as part of the
Company’s strategy.
The Company closed nine domestic distribution centers in 2023 pursuant to an approved restructuring plan or exit activity. With respect to finished goods held at a distribution center that is being closed as a result of a restructuring action or exit activity, the Company performs a cost benefit analysis to understand the profitability and incremental carrying cost and feasibility of relocating and holding such inventory versus liquidation, donation or destruction of the inventory prior to the facility closure. After performing such analyses, the Company concluded that there were stranded finished goods held at certain distribution centers that were being closed pursuant to an approved restructuring plan or exit activity. This resulted in write-downs of finished goods of approximately $25 million for the twelve months ending December 31, 2023 to reduce the carrying value of such inventory to its realizable value as necessary to facilitate the clearance of such inventory. In addition, following a comprehensive assessment as part of its strategy, the Company decided to exit several brands prior to the end of 2023, which decision necessitated a further write-down of $6 million to reduce the carrying value of inventory impacted by a brand exit in the Home and Commercial Solutions segment to its then-realizable value.
None of the write-downs described above reflect ordinary course decision-making regarding the timing, method and pricing of inventory. Rather, these write-downs are directly attributable to and would not have been incurred absent the restructuring actions or exit activities associated with the Company’s multi-year transformation. The Company believes that by excluding the inventory write-down charges specifically related to a restructuring action or exit activity, investors are provided with additional information that enhances the comparability of the Company’s underlying operating results period-over-period.
Construction-in-progress
(“CIP”) impairment charges: In the ordinary course of business, the Company approves capital expenditures for equipment to be used at its distribution centers, warehouses and manufacturing facilities, which expenditures are capitalized and classified as CIP on the Company’s Consolidated Balance Sheet prior to the equipment being put into service. In connection with an approved restructuring action resulting in the closure of a facility, the Company assesses any CIP at such facility and determines if there is an alternative future use or potential buyer for such CIP. To the extent there is no alternative future use or potential buyer, the Company will write-off the underlying CIP assets. The write-down of CIP associated with the closure of manufacturing facilities, distribution centers, or warehouses is directly attributable to a restructuring action and would not have been incurred absent the action.
right-of-use (“ROU”) asset facility exit costs: The Company presents the corresponding lease expense associated with restructured ROU assets, lease exit costs, and other facility costs associated with the exited facility as a non-GAAP restructuring-related cost. The Company believes that such costs are not representative of ongoing operating expenses of the Company and directly related to a restructuring action or exit activity.
Costs associated with decommissioning assets: The Company incurs certain costs to dismantle and decommission machinery and equipment as well as fixtures within facilities associated with a restructuring action prior to exiting the facility. The Company believes decommissioning costs represent incremental charges that are directly attributable to a restructuring action and would not have been incurred absent the action.
Gain on disposition of assets associated with a restructuring action: In connection with the Company’s restructuring actions, the Company will market and sell certain of the underlying assets located at exited facilities where it believes there is a buyer(s) for such assets. At the time of approval to sell, the Company will write-down the underlying asset to its approximate fair value less cost to sell. Upon closing the sale of the disposed asset, the Company will record a gain or loss based upon on the final agreed upon selling price. For example, pursuant to an approved restructuring action the Company closed a manufacturing facility in its Outdoor and
Recreation segment and subsequently realized a $17 million gain on disposition. The Company believes that the gain on disposition was directly attributable to the restructuring action and would not have been consummated absent the action. Therefore, the gain on disposition was presented as a restructuring-related non-GAAP adjustment and excluded from the Company’s normalized results.
First report after the company's reply of Oct 4, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
As a related matter, in future filings, please quantify the individual components of the restructuring and restructuring related non-GAAP adjustment, including identifying what portion of the adjustment is related to restructuring costs versus restructuring related costs.
The Company respectfully acknowledges the Staff’s comment and refers the Staff to Appendix A for an illustrative disclosure to address the Staff’s comment, which the Company anticipates will be substantially similar to the disclosure it will use commencing with the Company’s earnings release furnished on Form 8-K for the quarter ending September 30, 2024 and on a going forward basis for each applicable non-GAAP measure.Read in the reply
APPENDIX A
* * * * * * *
The following tables present a reconciliation of certain non-GAAP financial measures to the most directly comparable financial measures inRest of the answer
accordance with GAAP for the three and six months ended June 30, 2024 and a comparison to prior year. The Company has chosen to present the following non-GAAP measures to investors to enable additional analyses of past, present and future operating performance and as a supplemental means of evaluating the Company’s performance and operating results absent the effect of certain items that are deemed to be stand-alone items apart from the Company’s core operations (“Normalized Adjustments”). While these costs or gains are not expected to continue for any individual transaction on an ongoing basis, similar types of costs, expenses and charges or gains have occurred in prior periods.
Normalized Adjustments in 2024 and
2023 include the following:
Restructuring and restructuring-related costs
The Company incurs restructuring and restructuring-related costs in connection with various discrete initiatives, including previously disclosed initiatives such as our Realignment Plan, Network Optimization Project, Project Phoenix as well as other discrete actions. Restructuring charges primarily relate to severance and other employee termination costs as well as contract termination and other costs. Restructuring-related charges are costs that are directly attributable to a restructuring action and would not have been incurred absent the action. Restructuring-related charges primarily relate to duplicative costs pending facility closure, asset valuation adjustments and disposal gains, accelerated depreciation, and consulting costs. Restructuring-related costs primarily related to manufacturing and distribution personnel, facilities and assets are generally recorded in cost of products sold, while restructuring-related costs primarily related to office facilities and assets and professional or clerical personnel are generally recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations. Restructuring and restructuring-related charges primarily related to the Realignment Plan for the three and six months ended June 30, 2024 and to Project Phoenix for the comparable periods ended June 30, 2023, respectively.
Amortization expense and impairments of acquired intangible assets
Represents the amortization expense and impairment charges associated with acquired intangible assets.
Argentina hyperinflationary currency movements
Represents the favorable or unfavorable movement in Argentine pesos related to our subsidiary operating in Argentina, which is considered a hyperinflationary economy.
(Gain) loss on divestitures and transaction costs
Represents the gain or loss on disposal of a business, which represents the difference between the fair value (less costs to sell) and carrying value of the business being disposed, as well as transaction costs associated with acquisitions and divestitures.
Other adjustments
The following adjustments comprise other adjustments below: Legal expenses for certain proceedings primarily related to a completed U.S. Securities and Exchange Commission investigation as well as completed shareholder securities class action and derivative litigation which is disclosed in Note 18 (Litigation and Contingencies) to our audited consolidated financial statements contained in our most recent annual report on Form 10-K;
accelerated depreciation and amortization as well as the write-off of other assets associated with retail stores closure and software integration; the portion of a tax reserve associated with prior periods that was recorded due to the outcome of a judicial ruling relating to indirect taxes in an international entity; gains/losses arising from the mark-to-market of an investment with a readily determinable fair value; loss on modification of debt; loss on pension settlement; and an insurance recovery related to fire-related costs that were previously normalized.
Normalized income tax adjustments
The Company uses a “with” and “without” approach to calculate normalized income tax expense or benefit. At an interim period, the Company determines the year-to-date tax effect of the pretax items excluded from normalized results by allocating the difference between the calculated GAAP and calculated normalized tax expense or benefit. In addition, normalized income tax adjustments includes the income tax expense ($12 million and $14 million for the three months ended June 30, 2024 and 2023, respectively, $22 million and $23 million for the six months ended June 30, 2024 and
2023, respectively) that results from the amortization of a prior year normalized tax benefit.
NEWELL BRANDS INC.
RECONCILIATION OF GAAP AND NON-GAAP INFORMATION (UNAUDITED)
CERTAIN LINE ITEMS
(Amounts in millions, except per share amounts)
Three Months Ended
June 30,
Six Months Ended
2024
2023
Gross profit, as reported under GAAP
699
629
1,203
1,111
As a % of net sales
34.4
%
28.5
32.6
27.7
Normalized Adjustments:
Argentina hyperinflationary charge
Normalized gross profit
708
658
1,224
1,147
34.8
29.9
33.2
28.6
Operating income, as reported under GAAP
163
120
179
8.0
5.4
4.9
2.1
Restructuring
Severance and other employee termination costs
Contract termination and other costs
Restructuring-related costs classified in cost of products sold:
Restructuring-related costs classified in selling, general and administrative expenses:
(15
(13
Amortization of acquired intangible assets
Impairment of acquired intangible assets
Gain or loss on divestitures and transaction costs
Other, net
Normalized operating income
219
201
304
244
10.8
9.1
8.2
6.1
(Amounts in millions, except per share amounts)
Income (loss) before income taxes, as reported under GAAP
(81
(3
(4
Normalized income before income taxes
137
117
149
Income tax provision (benefit), as reported under GAAP
(12
Effective income tax rates, as reported under GAAP
46.4
48.6
(50.0
)%
3.7
(53
Normalized income tax provision (benefit)
(14
Normalized effective income tax rates
(10.2
13.7
(4.0
16.7
Net income (loss), as reported under GAAP
(84
Normalized net income
151
101
155
Diluted earnings (loss) per share, as reported under GAAP
0.11
0.04
0.09
(0.20
0.02
0.05
0.08
0.14
0.01
0.06
0.07
(0.04
(0.03
0.12
(0.01
0.13
Normalized diluted earnings per share*
0.36
0.24
0.37
0.18
*
Totals may not add due to rounding.
First report after the company's reply of Oct 4, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
We have reviewed your response to comment 2 and note your views related to accelerated depreciation and inventory write-downs. Inventory write-downs related to your restructuring activities that result from strategic business decisions do not appear to be outside the normal course of operations. Please refer to Question 100.01 of Non- GAAP Compliance & Disclosure Interpretations.Rest of the question
With respect to the adjustment for accelerated depreciation, while the estimated useful lives of the assets associated with the adjustment were shortened as a result of your restructuring activities, they continue to contribute to the company’s operations through the end of their useful 1. lives and should not be excluded from your non-GAAP measures. In future filings, please discontinue making these adjustments to your non-GAAP measures.
The Company acknowledges that it will remove the above-referenced adjustments for inventory write-downs and accelerated depreciation related to restructuring activities from its non-GAAP measures when and if any relevant period is presented in the future. The Company will present these changes commencing with the Company’s third quarter earnings release furnished on Form 8-K for the quarter ending September 30, 2024 and on a going-forward basis, as necessary.Read in the reply
First report after the company's reply of Oct 23, 2024: 10-Q filed Oct 25, 2024 ↗, against the 10-Q filed Jul 26, 2024 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2024-10-24